Atlas Trials

Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer

Clinical trial NCT05228743 · UNKNOWN

Trial details

NCT number
NCT05228743
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2020-09-01
Primary completion
2023-08-31
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.